Galanin receptor 3 - a potential target for acute pancreatitis therapy

Neurogastroenterology and Motility

Volumn 23, Issue 3, 2011, Pages e141-e151

  Barreto, S G ^a   Bazargan, M ^a   Zotti, M ^a   Hussey, D J ^a   Sukocheva, O A ^a   Peiris, H ^a   Leong, M ^a   Keating, D J ^a   Schloithe, A C ^a   Carati, C J ^a   Smith, C ^a   Toouli, J ^a   Saccone, G T P ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Acute pancreatitis; galanin; galanin receptor 3; galanin receptors

Indexed keywords

AMYLASE; CERULETIDE; GALANIN RECEPTOR 2; GALANIN RECEPTOR 3; GALANTIDE; M 871; MESSENGER RNA; OPIATE AGONIST; RNA; SNAP 37889; UNCLASSIFIED DRUG;

ACINAR CELL; ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME RELEASE; GENE AMPLIFICATION; GENE EXPRESSION; GENE LOCATION; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PANCREAS; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 79551699938     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2010.01662.x     Document Type: Article

References (44)

1. Barreto SG, Rodrigues J. Comparison of APACHE II and Imrie Scoring Systems in predicting the severity of acute pancreatitis. World J Emerg Surg 2007; 2: 33.
2. Barreto SG, Rodrigues J. Acute pancreatitis in Goa - a hospital-based study. J Indian Med Assoc 2008; 106: 575-6.
3. Lund H, Tonnesen H, Tonnesen MH, Olsen O. Long-term recurrence and death rates after acute pancreatitis. Scand J Gastroenterol 2006; 41: 234-8.
4. Williams M, Simms HH. Prognostic usefulness of scoring systems in critically ill patients with severe acute pancreatitis. Crit Care Med 1999; 27: 901-7.
5. Tatemoto K, Rokaeus A, Jornvall H, McDonald TJ, Mutt V. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 1983; 164: 124-8.
6. Bhandari M, Thomas AC, Hussey DJ et al. Galanin mediates the pathogenesis of cerulein-induced acute pancreatitis in the mouse. Pancreas 2010; 39: 182-7.
7. Brooke-Smith ME, Carati CJ, Bhandari M, Toouli J, Saccone GT. Galanin in the regulation of pancreatic vascular perfusion. Pancreas 2008; 36: 267-73.
8. Barreto SG, Carati CJ, Schloithe AC, Toouli J, Saccone GT. The combination of neurokinin-1 and galanin receptor antagonists ameliorates caerulein-induced acute pancreatitis in mice. Peptides 2010; 31: 315-21.
9. Bhandari M, Thomas A, Carati C, Kawamoto M, Toouli J, Saccone G. Galanin antagonism modifies hyperenzymemia and pancreatic vascular perfusion (PVP) changes induced by acute pancreatitis (AP) in a possum model. Pancreas 2006; 33: 447-8.
10. Messell T, Harling H, Bottcher G, Johnsen AH, Holst JJ. Galanin in the porcine pancreas. Regul Pept 1990; 28: 161-76.
11. Adeghate E, Ponery AS. Large reduction in the number of galanin-immunoreactive cells in pancreatic islets of diabetic rats. J Neuroendocrinol 2001; 13: 706-10.
12. Baltazar ET, Kitamura N, Hondo E, Narreto EC, Yamada J. Galanin-like immunoreactive endocrine cells in bovine pancreas. J Anat 2000; 196(Pt 2): 285-91.
13. Barreto SG, Carati CJ, Toouli J, Saccone GT. The islet-acinar axis of the pancreas: more than just insulin. Am J Physiol Gastrointest Liver Physiol 2010; 299: G10-22.
14. Ahren B, Andren-Sandberg A, Nilsson A. Galanin inhibits amylase secretion from isolated rat pancreatic acini. Pancreas 1988; 3: 559-62.
15. Flowe KM, Lally KM, Mulholland MW. Galanin inhibits rat pancreatic amylase release via cholinergic suppression. Peptides 1992; 13: 487-92.
16. Herzig KH, Brunke G, Schon I, Schaffer M, Folsch UR. Mechanism of galanin's inhibitory action on pancreatic enzyme secretion: modulation of cholinergic transmission - studies vivo and in vitro. Gut 1993; 34: 1616-21.
17. Runzi M, Muller MK, Schmid P, von Schonfeld J, Goebell H. Stimulatory and inhibitory effects of galanin on exocrine and endocrine rat pancreas. Pancreas 1992; 7: 619-23.
18. Barreto SG, Woods CM, Carati CJ et al. Galanin inhibits caerulein-stimulated pancreatic amylase secretion via cholinergic nerves and insulin. Am J Physiol Gastrointest Liver Physiol 2009; 297: G333-9.
19. Barreto SG, Carati CJ, Schloithe AC, Toouli J, Saccone GT. Galanin potentiates supramaximal caerulein-stimulated pancreatic amylase secretion via its action on somatostatin secretion. Am J Physiol Gastrointest Liver Physiol 2009; 297: G1268-73.
20. Bartfai T, Langel U, Bedecs K et al. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci U S A 1993; 90: 11287-91.
21. Merchenthaler I, Lopez FJ, Negro-Vilar A. Colocalization of galanin and luteinizing hormone-releasing hormone in a subset of preoptic hypothalamic neurons: anatomical and functional correlates. Proc Natl Acad Sci USA 1990; 87: 6326-30.
22. Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, Mayaux JF. Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci USA 1994; 91: 9780-3.
23. Sollenberg U, Lundstrom L, Bartfai T, Langel U. M871 - a novel peptide antagonist selectively recognizing the galanin receptor type 2. Int J Pept Res Ther 2006; 12: 115-9.
24. Swanson CJ, Blackburn TP, Zhang X et al. Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci USA 2005; 102: 17489-94.
25. Rifai Y, Elder AS, Carati CJ et al. The tripeptide analog feG ameliorates severity of acute pancreatitis in a caerulein mouse model. Am J Physiol Gastrointest Liver Physiol 2008; 294: G1094-9.
26. Nuovo GJ, Elton TS, Nana-Sinkam P, Volinia S, Croce CM, Schmittgen TD. A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets. Nat Protoc 2009; 4: 107-15.
27. Moore-Olufemi SD, Xue H, Attuwaybi BO et al. Resuscitation-induced gut edema and intestinal dysfunction. J Trauma 2005; 58: 264-70.
28. Schmidhuber SM, Santic R, Tam CW, Bauer JW, Kofler B, Brain SD. Galanin-like peptides exert potent vasoactive functions in vivo. J Invest Dermatol 2007; 127: 716-21.
29. Bang UC, Semb S, Nojgaard C, Bendtsen F. Pharmacological approach to acute pancreatitis. World J Gastroenterol 2008; 14: 2968-76.
30. Brooke-Smith M, Sandstrom P, Carati C, Thomas A, Toouli J, Saccone G. Necrosis and reduced vascular perfusion in models of moderate and severe acute pancreatitis. Pancreatology 2003; 3: 261.
31. Kawamoto M, Bhandari M, Thomas A, Carati C, Toouli J, Saccone G. The galanin antagonists galantide and M35 but not M40 ameliorate caerulein-induced acute pancreatitis in mice. Pancreatology 2007; 7: 231.
32. Schmidhuber SM, Starr A, Wynick D, Kofler B, Brain SD. Targeted disruption of the galanin gene attenuates inflammatory responses in murine skin. J Mol Neurosci 2008; 34: 149-55.
33. Barreto S, Carati C, Schloithe A et al. The efficacy of combining feG and galantide in mild caerulein-induced acute pancreatitis in mice. Peptides 2010; 31: 1076-82.
34. McGregor DP. Discovering and improving novel peptide therapeutics. Curr Opin Pharmacol 2008; 8: 616-9.
35. Diaz-Cabiale Z, Parrado C, Vela C et al. Role of galanin and galanin(1-15) on central cardiovascular control. Neuropeptides 2005; 39: 185-90.
36. Kolakowski LF Jr, O'Neill GP, Howard AD et al. Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. J Neurochem 1998; 71: 2239-51.
37. Li X, Hussey D, Mayne G et al. Galanin receptors 1, 2 and 3 are expressed in the normal mouse pancreas. Pancreatology 2007; 7: 230.
38. Branchek T, Smith KE, Walker MW. Molecular biology and pharmacology of galanin receptors. Ann NY Acad Sci 1998; 863: 94-107.
39. Schmidhuber SM, Rauch I, Kofler B, Brain SD. Evidence that the modulatory effect of galanin on inflammatory edema formation is mediated by the galanin receptor 3 in the murine microvasculature. J Mol Neurosci 2009; 37: 177-81.
40. Trejter M, Brelinska R, Warchol JB et al. Effects of galanin on proliferation and apoptosis of immature rat thymocytes. Int J Mol Med 2002; 10: 183-6.
41. Kanazawa T, Kommareddi PK, Iwashita T et al. Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells. Clin Cancer Res 2009; 15: 2222-30.
42. Bjorkqvist M, Bernsand M, Eliasson L, Hakanson R, Lindstrom E. Somatostatin, misoprostol and galanin inhibit gastrin- and PACAP-stimulated secretion of histamine and pancreastatin from ECL cells by blocking specific Ca2+ channels. Regul Pept 2005; 130: 81-90.
43. Barreto SG, Carati CJ, Schloithe AC, Toouli J, Saccone GT. Octreotide negates the benefit of galantide when used in the treatment of caerulein-induced acute pancreatitis in mice. HPB (Oxford) 2010; 12: 403-11.
44. Brodish RJ, Kuvshinoff BW, Fink AS, McFadden DW. Inhibition of pancreatic exocrine secretion by galanin. Pancreas 1994; 9: 297-303.